|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2004-10-25
|
|
pubmed:abstractText |
Targeting 2-hr postdose cyclosporine (C2) levels to 1,000 to 1,700 mg/dL during the first 6 months after renal transplantation is recommended for triple immunosuppressive regimens. This trial determines whether lower C2 levels could be targeted safely in de novo kidney transplant recipients under a quadruple regimen compared with a similar cohort monitored with trough (C0) levels.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
78
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1198-203
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15502720-Adrenal Cortex Hormones,
pubmed-meshheading:15502720-Adult,
pubmed-meshheading:15502720-Antilymphocyte Serum,
pubmed-meshheading:15502720-Antimetabolites,
pubmed-meshheading:15502720-Cohort Studies,
pubmed-meshheading:15502720-Cost Control,
pubmed-meshheading:15502720-Cyclosporine,
pubmed-meshheading:15502720-Dose-Response Relationship, Drug,
pubmed-meshheading:15502720-Drug Costs,
pubmed-meshheading:15502720-Drug Monitoring,
pubmed-meshheading:15502720-Drug Therapy, Combination,
pubmed-meshheading:15502720-Female,
pubmed-meshheading:15502720-Humans,
pubmed-meshheading:15502720-Immunosuppressive Agents,
pubmed-meshheading:15502720-Kidney Transplantation,
pubmed-meshheading:15502720-Male,
pubmed-meshheading:15502720-Middle Aged,
pubmed-meshheading:15502720-Prospective Studies,
pubmed-meshheading:15502720-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Cyclosporine minimization and cost reduction in renal transplant recipients receiving a C2-monitored, cyclosporine-based quadruple immunosuppressive regimen.
|
|
pubmed:affiliation |
Department of Pharmacy, Barnes-Jewish Hospital, Washington University, One Barnes-Jewish Hospital Plaza, St. Louis, MO 63110, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
